Recombinant SARS-CoV Nucleocapsid Protein

The Recombinant SARS-CoV Nucleocapsid Protein is a highly purified and bioactive protein that is produced through recombinant DNA technology. This protein is derived from the nucleocapsid of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and is an essential component of the virus. The Recombinant SARS-CoV Nucleocapsid Protein is a valuable tool for researchers studying the virus and its interactions with host cells.

This protein is produced in a highly controlled environment using advanced techniques to ensure its purity and bioactivity. It is supplied in a lyophilized form, which allows for easy storage and transportation. The Recombinant SARS-CoV Nucleocapsid Protein is suitable for a wide range of applications, including ELISA, Western blotting, and other immunoassays.

The Recombinant SARS-CoV Nucleocapsid Protein is a reliable and high-quality product that is essential for researchers studying the SARS-CoV virus. Its purity and bioactivity make it an ideal tool for a wide range of applications, and its lyophilized form ensures easy storage and transportation. Overall, the Recombinant SARS-CoV Nucleocapsid Protein is an essential component of any research project focused on understanding the SARS-CoV virus and its interactions with host cells.